These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20598637)

  • 1. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Nannini E; Murray BE; Arias CA
    Curr Opin Pharmacol; 2010 Oct; 10(5):516-21. PubMed ID: 20598637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
    Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
    Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for MRSA with reduced susceptibility to vancomycin.
    Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720
    [No Abstract]   [Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
    Vidaillac C; Leonard SN; Rybak MJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):527-30. PubMed ID: 20346632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD; Gelfand MS; Cleveland KO; Usery JB
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital.
    Panagea T; Galani I; Souli M; Karantani I; Giamarellou H; Petrikkos G
    Int J Antimicrob Agents; 2011 Nov; 38(5):451-2. PubMed ID: 21840688
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG; Gao W; Ward PB; Howden BP
    J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
    Pangercić A; Bukovski-Simonoski S; Barsić B
    Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vancomycin, what else?].
    Daurel C; Leclercq R
    Arch Pediatr; 2010 Sep; 17 Suppl 4():S121-8. PubMed ID: 20826319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods].
    Gómez-Garcés JL; López-Fabal F; Burillo A; Gil Y
    Rev Esp Quimioter; 2010 Jun; 23(2):87-92. PubMed ID: 20559607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.
    Chen CJ; Huang YC; Chiu CH
    J Antimicrob Chemother; 2015 Nov; 70(11):2965-72. PubMed ID: 26216581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.